Paper20065151
Tumor necrosis factor-alpha: a possible priming agent for the polymorphonuclear leukocyte-reduced nicotinamide-adenine dinucleotide phosphate oxidase in hypertension.
Mazor R and 6 others. Hypertension, 2010. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Tumor necrosis factor-alpha: a possible priming agent for the polymorphonuclear leukocyte-reduced nicotinamide-adenine dinucleotide phosphate oxidase in hypertension. Papers, record 20065151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20065151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tumor necrosis factor-alpha: a possible priming agent for the polymorphonuclear leukocyte-reduced nicotinamide-adenine dinucleotide phosphate oxidase in hypertension.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acetophenones | Major topic |
| Hypertension | Major topic |
| NADPH Oxidases | Major topic |
| Neutrophils | Major topic |
| Sodium Chloride, Dietary | Major topic |
| Tumor Necrosis Factor-alpha | Major topic |
| Analysis of Variance | |
| Animals | |
| Blood Pressure Determination | |
| Cytokines | |
| Disease Models, Animal | |
| Gene Expression Regulation | |
| Immunohistochemistry | |
| Malondialdehyde | |
| Oxidative Stress | |
| Probability | |
| Random Allocation | |
| Rats | |
| Rats, Inbred SHR |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40977717 | Inflammation: a key mechanism connecting metabolic-associated steatotic liver disease and systemic arterial hypertension. | Front Immunol | 2025 | https://conductscience.org/library/papers/40977717 | PubMed |
| 39989120 | Endothelial Cell Phenotypic Plasticity in Cardiovascular Physiology and Disease: Mechanisms and Therapeutic Prospects. | Am J Hypertens | 2025 | https://conductscience.org/library/papers/39989120 | PubMed |
| 38542788 | Role of Dietary Factors on DNA Methylation Levels of TNF-Alpha Gene and Proteome Profiles in Obese Men. | Nutrients | 2024 | https://conductscience.org/library/papers/38542788 | PubMed |
| 38504425 | Modulation of TNF-α, interleukin-6, and interleukin-10 by nebivolol-valsartan and nebivolol-lisinopril polytherapy in SHR rats. | Pharmacol Res Perspect | 2024 | https://conductscience.org/library/papers/38504425 | PubMed |
| 38275420 | Association between Psoriasis and Renal Functions: An Integration Study of Observational Study and Mendelian Randomization. | Biomedicines | 2024 | https://conductscience.org/library/papers/38275420 | PubMed |
| 36830627 | Interaction between Butyrate and Tumor Necrosis Factor α in Primary Rat Colonocytes. | Biomolecules | 2023 | https://conductscience.org/library/papers/36830627 | PubMed |
| 33594519 | Tumor Necrosis Factor Alpha and the Gastrointestinal Epithelium: Implications for the Gut-Brain Axis and Hypertension. | Cell Mol Neurobiol | 2022 | https://conductscience.org/library/papers/33594519 | PubMed |
| 27765883 | Inhibitory effects of telmisartan on culture and proliferation of and Kv1.3 potassium channel expression in peripheral blood CD4+ T lymphocytes from Xinjiang Kazakh patients with hypertension. | J Renin Angiotensin Aldosterone Syst | 2016 | https://conductscience.org/library/papers/27765883 | PubMed |
| 27069492 | Effects of Yishen Pinggan Recipe on Renal Protection and NF-κB Signaling Pathway in Spontaneously Hypertensive Rats. | Evid Based Complement Alternat Med | 2016 | https://conductscience.org/library/papers/27069492 | PubMed |
| 25395833 | Discovery and evaluation of novel anti-inflammatory derivatives of natural bioactive curcumin. | Drug Des Devel Ther | 2014 | https://conductscience.org/library/papers/25395833 | PubMed |
| 24503717 | Perivascular adipose tissue, vascular reactivity and hypertension. | Med Princ Pract | 2015 | https://conductscience.org/library/papers/24503717 | PubMed |
| 24049643 | The importance of myeloperoxidase in apocynin-mediated NADPH oxidase inhibition. | ISRN Inflamm | 2012 | https://conductscience.org/library/papers/24049643 | PubMed |
| 23734005 | An update on immune system activation in the pathogenesis of hypertension. | Hypertension | 2013 | https://conductscience.org/library/papers/23734005 | PubMed |
| 23507826 | Immune cell dysfunction and inflammation in end-stage renal disease. | Nat Rev Nephrol | 2013 | https://conductscience.org/library/papers/23507826 | PubMed |
| 22536381 | Tumor necrosis factor-alpha g308α gene polymorphism and essential hypertension: a meta-analysis involving 2244 participants. | PLoS One | 2012 | https://conductscience.org/library/papers/22536381 | PubMed |
| 21614553 | A novel synthetic mono-carbonyl analogue of curcumin, A13, exhibits anti-inflammatory effects in vivo by inhibition of inflammatory mediators. | Inflammation | 2012 | https://conductscience.org/library/papers/21614553 | PubMed |
| 21088577 | Mechanisms and consequences of salt sensitivity and dietary salt intake. | Curr Opin Nephrol Hypertens | 2011 | https://conductscience.org/library/papers/21088577 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20065151
GET https://conductscience.org/api/papers/v1/20065151/authors